Radiation Therapy Oncology Group study 94-08 analyzed 1979 males with prostate cancer , stage T1b-T2b and prostate-specific antigen concentrations of 20 ng/dL , to investigate whether 4 months of total androgen suppression ( TAS ) added to RT improved survival compared to RT alone .